期刊文献+

罗汉果皂苷提取物对实验性糖尿病大鼠的血管保护作用及机制 被引量:12

Protective effects of Momordica grosvenori extracts on blood vessels of diabetic rats and related mechanism
下载PDF
导出
摘要 目的观察不同病程(5、10周)的糖尿病(DM)大鼠氧化应激和血红素氧化酶(heme oxygenase,HO)-1系统的动态变化,探讨HO-1在DM血管病变发展进程中的作用,同时探讨天然抗氧化剂罗汉果皂苷(MG)对DM大鼠的血管保护作用及机制。方法雄性SD大鼠注射链脲佐菌素诱导DM模型。将实验大鼠分为正常对照组(C组)、正常+MG提取物组(C+MG组)、DM组(D组)和DM+MG提取物组(D+MG组),每组均为20只。C组和D组接受0.9%氯化钠溶液灌胃,C+MG组和D+MG组以罗汉果皂苷提取物150mg/kg灌胃。实验过程中每周监测体重,灌胃5、10周后分别检测血糖、血清中游离脂肪酸(FFA)含量以及血清总抗氧化能力(TAOC)和丙二醛(MDA)水平。取各组胸主动脉行常规病理学检查,应用免疫组织化学法检测肿瘤坏死因子(TNF)-α在各组血管组织的表达,应用逆转录-聚合酶链反应(RT-PCR)和Western印迹法检测HO-1mRNA和蛋白的表达,电子显微镜下观察血管内皮超微结构的改变。结果①与C组、C+MG组比较,D组、D+MG组各观察时间点的饮水量均显著增加(P值均<0.05),体重均显著减轻(P值均<0.05);从第3周起,D+MG组的饮水量显著少于D组(P<0.05);1周后,D+MG组的体重显著大于D组(P<0.05)。②D组、D+MG组5、10周的血糖均显著高于C组、C+MG组(P值均<0.05),D+MG组血糖显著低于D组(P<0.05);病程5周时,D组与C组间血清FFA的差异无统计学意义(P>0.05),10周时D组的血清FFA含量显著低于D+MG组(P<0.05)。③5、10周时,D组TAOC均显著低于C组(P值均<0.05),D+MG组显著高于D组(P值均<0.05);D组MDA水平显著高于C组(P值均<0.05),D+MG组显著低于D组(P值均<0.05)。④5周时,D组大鼠血管HO-1mRNA和蛋白水平均显著高于C组(P值均<0.05),D+MG组显著低于D组(P值均<0.05);10周时,D组大鼠血管HO-1mRNA和蛋白水平均显著低于C组(P值均<0.05),D+MG组显著高于D组(P值均<0.05)。⑤5周时D+MG组线粒体肿胀情况较D组减轻,所取标本也未见明显上皮脱落情况;10周时内皮损伤情况较5周时重,但较D组减轻,也未发现细胞核明显固缩、溶解破坏的情况。结论氧化应激在不同的时期通过影响(诱导或抑制)抗氧化应激蛋白HO-1系统参与DM血管病变的发生、发展过程。MG可以降糖、降FFA,并减轻DM发展进程中的氧化应激反应,保护血管内皮。其抗氧化作用的发挥可能由HO-1介导。 Objective To observe the heme oxygenase-1(HO-1) expression changes in rats with 5- and 10-week diabetes (DM) in the absence and presence of a natural antioxidant Momordica grosvenori (MG), and to assess the protective effect of MG on the blood vessels of DM rats. Methods Male Sprague-Dawley (SD) rats were made into diabetic model by a single intra-peritoneal injection of STZ (50 mg/kg). The rats were divided into normal control group (group C), normal control + MG (C-MG group), diabetic group (group D) and diabetes + MG group (D-MC group) ( n = 20). Control (n = 40) and diabetic rats (n=40) were treated with saline or MG (150 mg/kg 7 day) via gavage for 5 or 10 weeks. The body weight and blood glucose were determined on a weekly basis. Serum FFA, total antioxidant capacities (TAOC) and malondialdehyde (MDA) contents were measured. Vascular expression and distribution of tumor necrosis factor-α (TNF-α) were examined and observed by immunohsitochemistry in the thoracic aorta. HO-1 mRNA and protein expressions of vascular tissue were detected by RT-PCR and Western blotting assay. The ultrastructure of thoracic aorta was observed under the light microscope and transmission electron microscope. Results ① MG significantly attenuated the hyperglycemia, polydipsia and increased body weights of diabetic rats from the 3th week (P〈0.05). ② FAA remained unchanged at 5 weeks post STZ injection and significantly increased at 10 weeks post STZ injection, which was significantly reduced by MG (P〈0.05). ③ Serum TAOC was decreased in a time-dependent manner and the content of MDA was progressively increased in diabetic rats and these effects were partially reversed by MG ( P〈0.05).④The mRNA and protein expressions of HO-1 in the thoracic aorta of diabetic rats were significantly enhanced at 5th week and decreased at 10th week (P〈0.05); these changes were significantly attenuated by MG (P〈0.05).⑤ Imrnunohistochemical results demonstrated that MG significantly attenuated the increased TNF-a positive cells in aorta. Conclusion HO-1 is involved in the oxidative stress responses in DM rats. MG can attenuate vascular oxidative stress and angiopathies in DM rats through its anti-oxidative action by modulating HO-I. (Shanghai Med J, 2009, 32: 400-405)
出处 《上海医学》 CAS CSCD 北大核心 2009年第5期400-405,I0001,共7页 Shanghai Medical Journal
关键词 罗汉果皂苷 2型糖尿病 氧化应激 Momordica grosvenori Type 2 diabetes mellitus Oxidative stress
  • 相关文献

参考文献21

  • 1KanetoH,NakataniY,Kawamori D,et al.Role of oxidative stress,endoplasmic reticulum stress,and c-Jun Nterminal kinase in pancreatic beta-cell dysfunction and insulin resistance,Int J Biochem Cell Biol,2005,37:1595-1608.
  • 2Bonnefont-Rousselot D,Bastard J P,Jaudon M C,et al.Consequences of the diabetic status on the oxidant/ antioxidant balance.Diabetes Metab,2000,26:163-176.
  • 3Rube R C,McDonald R B.Use of antioxidant nutrients in the prevention and treatment of type 2 diabetes.J Am Coll Nutr,2001,20 (Suppl 5):S363-S369,S381-S383.
  • 4Guerrero-Romero F,Rodriguez-Moran M.Complementary therapies for diabetes:the case for chromium,magnesium,and antioxidants.Arch Med Res,2005,86:250-257.
  • 5Rahimi R,Nikfar S,Larijani B,et al.A review on the role of antioxidants in the management of diabetes and its complications.Biomed Pharmacother,2005,59:365-373.
  • 6陈可桢,胡勇,林厚文,张纯,刘皋林.植物中降血糖活性成分研究进展[J].上海医药,2002,23(11):493-496. 被引量:7
  • 7戚向阳,陈维军,宋云飞,谢笔钧.罗汉果对糖尿病小鼠的降血糖作用[J].食品科学,2003,24(12):124-127. 被引量:39
  • 8Brownlee M.Biochemistry and molecular cell biology of diabetic complications.Nature,2001,414:813-820.
  • 9Maxwell S R,Thomason H,Sandier D,et al.Antioxidant status in patients with uncomplicated insulin-dependent and non-insulin-dependent diabetes mellitus.Eur J Clin Invest,1997,27:484-490.
  • 10Nishikswa T,Edelstein D,Du X L,et al.Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage.Nature,2000,404:787-790.

二级参考文献34

共引文献43

同被引文献231

引证文献12

二级引证文献109

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部